WHO Warns Against Three Indian Cough Syrups
The World Health Organization (WHO) has issued a global alert against three Indian cough syrups: Coldrif, Respifresh TR, and ReLife. Tests revealed they contained diethylene glycol (DEG), a toxic chemical, at levels far above safety limits.
Linked Child Deaths
At least 17 children in Madhya Pradesh died after consuming Coldrif syrup. Laboratory results showed DEG levels of nearly 48.6 %, hundreds of times beyond permissible limits. While no confirmed deaths are linked to Respifresh TR or ReLife, both syrups were also found contaminated and recalled.
No Export, Says Regulator
India’s drug regulator CDSCO confirmed that none of the toxic syrups were exported abroad. The U.S. FDA has also stated there is no sign these products entered American markets.
Global Alert and Risks
WHO has urged countries worldwide to inspect supply chains and block circulation of the syrups. It warned the medicines pose severe, potentially fatal risks to children and could spread through unregulated sales channels.
Action Taken
Indian authorities have banned the sale of all three syrups. The maker of Coldrif, Sresan Pharmaceuticals, has had its licence permanently revoked, and its unit in Tamil Nadu shut down. Investigations are ongoing, and accountability measures are expected.
